RecruitingNCT05568966

Collection of Blood Samples for New Diagnostic Devices 2

Collection of Venous and Capillary Blood Samples for the Research, Optimisation and Calibration of New Diagnostic Devices 2


Sponsor

LumiraDx UK Limited

Enrollment

20,000 participants

Start Date

Jul 11, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

To research and develop new state of the art diagnostic biomarkers on the LumiraDx Platform that are comparable to the approved gold standard reference methods and will radically enhance clinicians and patients ability to monitor health conditions and improve outcomes by delivering the results near patient at the point of care.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Fingerstick and Venous blood draw for people with cardiovascular, embolism and thrombosis, and other related conditions. The study is currently recruiting participants at 7 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTVenous blood draw

Venepuncture to draw up to 24mL of venous blood.

DIAGNOSTIC_TESTFingerstick

Capillary blood draw


Locations(7)

University Hospital Monklands

Airdrie, Scotland, United Kingdom

Royal Infirmary of Edinburgh

Edinburgh, Scotland, United Kingdom

St John's Hospital

Edinburgh, Scotland, United Kingdom

Glasgow Royal Infirmary

Glasgow, Scotland, United Kingdom

Queen Elizabeth University Hospital

Glasgow, Scotland, United Kingdom

Golden Jubilee National Hospital

Glasgow, Scotland, United Kingdom

Royal Alexandra Hospital

Paisley, Scotland, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05568966


Related Trials